miR-3648 promotes lung adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine signaling 2)

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020;468:82–87.
   PubMed Web of Science ®Google Scholar
• Ruiz-Cordero R, Devine WP. Targeted therapy and checkpoint immunotherapy in lung cancer. Surg Pathol Clin. 2020;13(1):17–33.
   PubMedGoogle Scholar
• Vansteenkiste J, Crinò L, Dooms C, et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462–1474.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Bunn PA Jr. Adjuvant TKIs in NSCLC: what can we learn from RADIANT? Nat Rev Clin Oncol. 2015;12(12):689–690.
   PubMed Web of Science ®Google Scholar
• Steven A, Fisher SA, Robinson BW. Immunotherapy for lung cancer. Respirology. 2016;21(5):821–833.
   PubMed Web of Science ®Google Scholar
• Sampath S. Treatment: radiation Therapy. Cancer Treat Res. 2016;170:105–118.
   PubMedGoogle Scholar
• Ahn MJ, Sun JM, Lee SH, et al. EGFR TKI combination with immunotherapy in non-small cell lung cancer. Expert Opin Drug Saf. 2017;16(4):465–469.
   PubMed Web of Science ®Google Scholar
• Gainor JF, Varghese AM, Ou SH, et al. ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2013;19(15):4273–4281.
   PubMed Web of Science ®Google Scholar
• Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117.
   PubMedGoogle Scholar
• Hu Y, Dingerdissen H, Gupta S, et al. Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis. Comput Biol Med. 2018;103:183–197.
   PubMed Web of Science ®Google Scholar
• Xing R. miR-3648 promotes prostate cancer cell proliferation by inhibiting adenomatous polyposis coli 2. J Nanosci Nanotechnol. 2019;19(12):7526–7531.
   PubMed Web of Science ®Google Scholar
• Sun W, Li S, Yu Y, et al. MicroRNA-3648 is upregulated to suppress TCF21, resulting in promotion of invasion and metastasis of human bladder cancer. Mol Ther Nucleic Acids. 2019;16:519–530.
   PubMedGoogle Scholar
• Rashid F, Awan HM, Shah A, et al. Induction of miR-3648 Upon ER stress and its regulatory Role in cell proliferation. Int J Mol Sci. 2017;18(7):1375.
   PubMed Web of Science ®Google Scholar
• Lin GB, Zhang CM, Chen XY, et al. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer. Math Biosci Eng. 2019;17(1):834–844.
   PubMed Web of Science ®Google Scholar
• Emmadi R, Canestrari E, Arbieva ZH, et al. Correlative analysis of miRNA expression and Oncotype Dx recurrence score in estrogen receptor positive breast carcinomas. PloS One. 2015;10(12):e0145346.
   PubMed Web of Science ®Google Scholar
• Letellier E, Haan S. SOCS2: physiological and pathological functions. Front Biosci (Elite Ed). 2016;8:189–204.
   PubMedGoogle Scholar
• Zheng Z, Li X, You H, et al. LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264. Aging (Albany NY). 2020;12(11):10517–10526.
   PubMedGoogle Scholar
• Das R, Gregory PA, Fernandes RC, et al. MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2. Cancer Res. 2017;77(4):1021–1034.
   PubMed Web of Science ®Google Scholar
• Liu W, Liu P, Gao H, et al. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition. Mol Oncol. 2020;14(10):2660–2677.
   PubMed Web of Science ®Google Scholar
• Zheng HB, Zheng XG, Liu BP. miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2. Int J Clin Exp Med. 2015;8(11):20263–20270.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xia Y, Li L, et al. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol Ther. 2015;16(1):160–169.
   PubMed Web of Science ®Google Scholar
• Tong JL, Wang LL, Ling XF, et al. MiR-875 can regulate the proliferation and apoptosis of non-small cell lung cancer cells via targeting SOCS2. Eur Rev Med Pharmacol Sci. 2019;23(12):5235–5241.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu S, Zhou Z, et al. A herpes simplex virus type 2-encoded microRNA promotes tumor cell metastasis by targeting suppressor of cytokine signaling 2 in lung cancer. Tumour Biol. 2017;39(5):1010428317701633.
   Google Scholar
• Chhabra Y, Wong HY, Nikolajsen LF, et al. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene. 2018;37(4):489–501.
   PubMed Web of Science ®Google Scholar
• Chung CT, Yeh KC, Lee CH, et al. Molecular profiling of Afatinib-resistant non-small cell lung cancer cells in vivo derived from mice. Pharmacol Res. 2020;161:105183.
   PubMed Web of Science ®Google Scholar
• Chen C, Tan R, Wong L, et al. Quantitation of microRNAs by real-time RT-qPCR. Methods Mol Biol. 2011;687:113–134.
   PubMedGoogle Scholar
• Luo H, Xu C, Le W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou J, Xiao S. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Anticancer Drugs. 2020;31(9):932–941.
   PubMed Web of Science ®Google Scholar
• Rodriguez LG, Wu X, Guan JL. Wound-healing assay. Methods Mol Biol. 2005;294:23–29.
   PubMedGoogle Scholar
• Clément T, Salone V, Rederstorff M. Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015;1296:187–198.
   PubMedGoogle Scholar
• Bierhoff H. Analysis of lncRNA-Protein interactions by RNA-protein pull-down assays and RNA Immunoprecipitation (RIP). Methods Mol Biol. 2018;1686:241–250.
   PubMedGoogle Scholar
• Song Y, Shan B, Zeng S, et al. Raw and wine processed Schisandra chinensis attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway. J Ethnopharmacol. 2021;266:113426.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang Z, Wang N, et al. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma. Cell Death Dis. 2018;9(4):429.
   PubMedGoogle Scholar
• Letellier E, Schmitz M, Baig K, et al. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer. 2014;111(4):726–735.
   PubMed Web of Science ®Google Scholar
• Hoefer J, Kern J, Ofer P, et al. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocr Relat Cancer. 2014;21(2):175–187.
   PubMed Web of Science ®Google Scholar
• Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–2270.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Du J, et al. MiR-3613-3p from carcinoma-associated fibroblasts exosomes promoted breast cancer cell proliferation and metastasis by regulating SOCS2 expression. IUBMB Life. 2020;72(8):1705–1714.
   PubMed Web of Science ®Google Scholar
• Wikman H, Kettunen E, Seppänen JK, et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 2002;21(37):5804–5813.
   PubMed Web of Science ®Google Scholar
• Yang B, Zhao F, Yao L, et al. CircRNA circ_0006677 inhibits the progression and glycolysis in Non-Small-Cell lung cancer by Sponging miR-578 and regulating SOCS2 expression. Front Pharmacol. 2021;12:657053.
   PubMed Web of Science ®Google Scholar